VITROS Anti SARS-CoV-2 IgG Controls for Immunodiagnostic Determination of SARS-CoV-2 IgG Antibodies by Enhanced Chemiluminescence on VITROS Analyzers, Lot 0150

VITROS Anti SARS-CoV-2 IgG Controls for Immunodiagnostic Determination of SARS-CoV-2 IgG Antibodies by Enhanced Chemiluminescence on VITROS Analyzers, Lot 0150

This set of control samples is intended for the immunodiagnostic detection of class G immunoglobulins (IgG) to SARS-CoV-2 using the enhanced chemiluminescence method on VITROS series analyzers.

Kit contents (Lot 0150):

• Control 1 (Negative Control) – 3 vials, each 2.0 ml
• Control 2 (Positive Control) – 3 vials, each 2.0 ml

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, VITROS Anti SARS-CoV-2 IgG Controls for Immunodiagnostic Determination of SARS-CoV-2 IgG Antibodies by Enhanced Chemiluminescence on VITROS Analyzers, Lot 0150, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.